Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Biologic Trials

Research area

Pancreatic Cancer biologic therapy trials

Every pancreatic cancer study listed here tests a biologic, such as a vaccine, an antibody, or a cell or gene therapy. Whether you are looking for yourself or for someone you care for, Cancer Biologic Trials can help you find out if a study may be a fit.

Updated

Call (888) 343-5902
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Pancreatic cancer biologic therapy studies in numbers

pancreatic cancer biologic therapy studies recruiting in the U.S.
32
states with a study site
36

Source: ClinicalTrials.gov. Data processed .

Find pancreatic cancer biologic therapy studies by state

These states have the most studies recruiting right now.

Pancreatic cancer biologic therapy studies recruiting now

As of November 18, 2026, 32 pancreatic cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.

What they test

  • biologics such as vaccines or antibodies32
  • medications17
  • procedures8
  • other approaches2
  • devices1

A study can test more than one.

Main purpose

  • treating a condition30
  • diagnosis1
  • other purposes1

Phase

  • Early Phase 11
  • Phase 120
  • Phase 1/27
  • Phase 22
  • Phase 32

Who runs them

  • industry14
  • university, hospital or other12
  • government6

Who they enroll

  • adults (18 to 64)32
  • older adults (65 and over)32

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 32 studies.

Recently updated pancreatic cancer biologic therapy studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Boston, MA · Chicago, IL · Columbus, OH · and 9 more U.S. locations
    Registry record
    NCT05372614 · updated
  2. Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Loki Therapeutics, Inc.
    Recruiting in
    The Bronx, NY
    Registry record
    NCT07828236 · updated
  3. Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

    • Phase 1/2
    • Ages 18 to 72
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT03190941 · updated
  4. A Study of MGC030 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Recruiting in
    Lake Success, NY
    Registry record
    NCT07822399 · updated
  5. A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora, CO · Gainesville, FL · Houston, TX · and 5 more U.S. locations
    Registry record
    NCT06428409 · updated
  6. Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Pittsburgh, PA
    Registry record
    NCT07619521 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in the United States on ClinicalTrials.gov.

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

What pancreatic cancer biologic therapy studies look at

Every pancreatic cancer study you see on Cancer Biologic Trials tests a biologic. That could be a vaccine, an antibody, or a cell or gene therapy. A study is set up to answer a single, specific question. So what one asks of you, or of the person you are reading for, can look quite different from what another asks.

The word to know is investigational, and it applies to anything a study is testing. Put plainly, its risks and how well it works are open questions that researchers have not finished answering. Finding those answers is why the study is being run at all.

Who may be able to take part

Requirements are set study by study. Age can be one, along with health history, the medications you take now, and how a condition affects you. There are also studies that enroll people who do not have the condition.

Working out eligibility is not something you have to do alone, and the same goes if you are reading for a family member. The study team checks it at a screening visit. Here is how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    Nothing else happens until you have talked with a coordinator, who describes the biologic study in general terms and takes your questions, or your family's.

  2. Informed consent

    Full details of the biologic study then reach you in writing from the study team, and the risks that are known are spelled out there too. Whether you say yes is your decision alone.

  3. Screening

    Screening is a mix of health questions and tests. The answers and results tell the study team whether this particular biologic study suits you, and some people who are screened do not go on to take part.

  4. Study visits

    If you do join, the visits are scheduled ahead, and you attend them so the team can follow your health as the biologic study goes on. Leaving is always open to you, at any point.

Questions about pancreatic cancer biologic therapy studies

Do I need a diagnosis to join a study about pancreatic cancer?

There is no single answer. Some pancreatic cancer biologic trials want the diagnosis already confirmed before you start. Others do the assessing themselves at the screening stage. The study team will let you know which applies.

Would I have to change the care I receive now?

Please do not change anything about your care on your own. It depends on the study: in some biologic studies people stay on the care they already have, and in others they cannot. The study doctor goes over this with you, and you are welcome to talk it through with your own doctor before you decide.

Is there a cost to take part?

As a rule, people taking part in a pancreatic cancer biologic trial are not charged for the tests the study requires, the visits it schedules, or the biologic being studied. Our guide to costs and compensation goes into more detail.

Ask about pancreatic cancer biologic therapy studies

Send us a few details about yourself, or about the person you are helping. A coordinator then reaches out to you. You are not signing up for a study by asking.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-5902

or send a short form

How should we reach you?

Call